Details for Patent: 8,361,977
✉ Email this page to a colleague
Which drugs does patent 8,361,977 protect, and when does it expire?
Patent 8,361,977 protects SPINRAZA and is included in one NDA.
This patent has thirty-one patent family members in twelve countries.
Summary for Patent: 8,361,977
| Title: | Compositions and methods for modulation of SMN2 splicing |
| Abstract: | Disclosed herein are compounds, compositions and methods for modulating splicing of SMN2 mRNA in a cell, tissue or animal. Also provided are uses of disclosed compounds and compositions in the manufacture of a medicament for treatment of diseases and disorders, including spinal muscular atrophy. |
| Inventor(s): | Baker; Brenda F. (Carlsbad, CA), Krainer; Adrian R. (Huntington Station, NY), Hua; Yimin (Jericho, NY) |
| Assignee: | Isis Pharmaceuticals, Inc. (Carlsbad, CA) |
| Application Number: | 11/993,609 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; |
Recent additions to Drugs Protected by US Patent 8,361,977
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Type | RLD | Patent No. | Product | Substance | Delist Req. | Patent Expiration | Usecode | Patented / Exclusive Use |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION | 209531 | Dec 23, 2016 | RX | Yes | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Type | >RLD | >Patent No. | >Product | >Substance | >Delist Req. | >Patent Expiration | >Usecode | >Patented / Exclusive Use |
Drugs Protected by US Patent 8,361,977
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biogen Idec | SPINRAZA | nusinersen sodium | SOLUTION;INTRATHECAL | 209531-001 | Dec 23, 2016 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
Foreign Priority and PCT Information for Patent: 8,361,977
| PCT Information | |||
| PCT Filed | June 23, 2006 | PCT Application Number: | PCT/US2006/024469 |
| PCT Publication Date: | January 04, 2007 | PCT Publication Number: | WO2007/002390 |
International Family Members for US Patent 8,361,977
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Cyprus | 1116663 | ⤷ Try a Trial | |||
| Cyprus | 1121134 | ⤷ Try a Trial | |||
| Cyprus | 2017040 | ⤷ Try a Trial | |||
| Denmark | 1910395 | ⤷ Try a Trial | |||
| Denmark | 2548560 | ⤷ Try a Trial | |||
| Denmark | 3308788 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
